Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-12-28 to 2023-01-09
Current total value of award: $1126.6
Description: 8509613234!TYPHOID VI POLYSACC